IRAKIMID Trademark

Trademark Overview

On Friday, January 10, 2020, a trademark application was filed for IRAKIMID with the United States Patent and Trademark Office. The USPTO has given the IRAKIMID trademark a serial number of 88754002. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 31, 2023. This trademark is owned by Kymera Therapeutics, Inc.. The IRAKIMID trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and medical preparations for the treatment of oncology, autoimmune, immune-oncology and other related diseases; pharmaceutical and medical therapeutics for the treatment of oncology, autoimmune, immune-oncology and other related diseases; diagnostic reagents for the treatment of oncology, autoimmune, immune-oncology and other related diseases
irakimid

General Information

Serial Number88754002
Word MarkIRAKIMID
Filing DateFriday, January 10, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 31, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 5, 2020

Trademark Statements

Goods and ServicesPharmaceutical and medical preparations for the treatment of oncology, autoimmune, immune-oncology and other related diseases; pharmaceutical and medical therapeutics for the treatment of oncology, autoimmune, immune-oncology and other related diseases; diagnostic reagents for the treatment of oncology, autoimmune, immune-oncology and other related diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 15, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKymera Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472
Party NameKymera Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, July 31, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 31, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, January 6, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 5, 2023SOU EXTENSION 5 GRANTED
Thursday, December 29, 2022SOU EXTENSION 5 FILED
Thursday, December 29, 2022SOU TEAS EXTENSION RECEIVED
Thursday, June 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 28, 2022SOU EXTENSION 4 GRANTED
Tuesday, June 28, 2022SOU EXTENSION 4 FILED
Tuesday, June 28, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, December 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 27, 2021SOU EXTENSION 3 GRANTED
Monday, December 27, 2021SOU EXTENSION 3 FILED
Monday, December 27, 2021SOU TEAS EXTENSION RECEIVED
Friday, July 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 30, 2021SOU EXTENSION 2 GRANTED
Wednesday, June 30, 2021SOU EXTENSION 2 FILED
Wednesday, June 30, 2021SOU TEAS EXTENSION RECEIVED
Saturday, April 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 16, 2021SOU EXTENSION 1 GRANTED
Wednesday, December 30, 2020SOU EXTENSION 1 FILED
Thursday, March 25, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 10, 2021NOTICE OF REVIVAL - E-MAILED
Tuesday, February 9, 2021SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, February 9, 2021PETITION TO REVIVE-GRANTED
Tuesday, February 9, 2021TEAS PETITION TO REVIVE RECEIVED
Monday, February 1, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 1, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 30, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 5, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 5, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 15, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 30, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 30, 2020ASSIGNED TO EXAMINER
Wednesday, January 15, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 14, 2020NEW APPLICATION ENTERED

Related Keywords

irakimid oncology other related diseases autoimmune immune treatment pharmaceutical medical reagents